369 related articles for article (PubMed ID: 29407980)
1. Fluoroquinolone derivatives and their anti-tubercular activities.
Fan YL; Wu JB; Cheng XW; Zhang FZ; Feng LS
Eur J Med Chem; 2018 Feb; 146():554-563. PubMed ID: 29407980
[TBL] [Abstract][Full Text] [Related]
2. Recent advances of pyrazole-containing derivatives as anti-tubercular agents.
Xu Z; Gao C; Ren QC; Song XF; Feng LS; Lv ZS
Eur J Med Chem; 2017 Oct; 139():429-440. PubMed ID: 28818767
[TBL] [Abstract][Full Text] [Related]
3. Triazole derivatives and their anti-tubercular activity.
Zhang S; Xu Z; Gao C; Ren QC; Chang L; Lv ZS; Feng LS
Eur J Med Chem; 2017 Sep; 138():501-513. PubMed ID: 28692915
[TBL] [Abstract][Full Text] [Related]
4. Recent developments of coumarin-containing derivatives and their anti-tubercular activity.
Hu YQ; Xu Z; Zhang S; Wu X; Ding JW; Lv ZS; Feng LS
Eur J Med Chem; 2017 Aug; 136():122-130. PubMed ID: 28494250
[TBL] [Abstract][Full Text] [Related]
5. Recent advances of imidazole-containing derivatives as anti-tubercular agents.
Fan YL; Jin XH; Huang ZP; Yu HF; Zeng ZG; Gao T; Feng LS
Eur J Med Chem; 2018 Apr; 150():347-365. PubMed ID: 29544148
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase.
Sriram D; Aubry A; Yogeeswari P; Fisher LM
Bioorg Med Chem Lett; 2006 Jun; 16(11):2982-5. PubMed ID: 16554151
[TBL] [Abstract][Full Text] [Related]
9. Isoniazid derivatives and their anti-tubercular activity.
Hu YQ; Zhang S; Zhao F; Gao C; Feng LS; Lv ZS; Xu Z; Wu X
Eur J Med Chem; 2017 Jun; 133():255-267. PubMed ID: 28390957
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitubercular evaluation of new fluoroquinolone derivatives coupled with carbohydrates.
Saraiva MF; de Souza MV; Tran Huu Dau ME; Araújo DP; de Carvalho GS; de Almeida MV
Carbohydr Res; 2010 Apr; 345(6):761-7. PubMed ID: 20167309
[TBL] [Abstract][Full Text] [Related]
11. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids.
Xu Z; Zhang S; Song X; Qiang M; Lv Z
Bioorg Med Chem Lett; 2017 Aug; 27(16):3643-3646. PubMed ID: 28720502
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of nitrofuranyl methyl N-heterocycles derivatives as novel antitubercular agents.
Wang A; Li W; Wang B; Lv K; Wang H; Liu M; Guo H; Lu Y
Future Med Chem; 2018 Sep; 10(17):2059-2068. PubMed ID: 29992836
[TBL] [Abstract][Full Text] [Related]
14. In silico assessment of adverse effects of a large set of 6-fluoroquinolones obtained from a study of tuberculosis chemotherapy.
Tusar M; Minovski N; Fjodorova N; Novic M
Curr Drug Saf; 2012 Sep; 7(4):313-20. PubMed ID: 23062244
[TBL] [Abstract][Full Text] [Related]
15. Novel ofloxacin derivatives: synthesis, antimycobacterial and toxicological evaluation.
Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
Bioorg Med Chem Lett; 2008 Feb; 18(3):1229-36. PubMed ID: 18068979
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of fluoroquinolone resistance in Mycobacterium tuberculosis.
Zhang YJ; Li XJ; Mi KX
Yi Chuan; 2016 Oct; 38(10):918-927. PubMed ID: 27806933
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitubercular activity of palladium and platinum complexes with fluoroquinolones.
Vieira LM; de Almeida MV; Lourenço MC; Bezerra FA; Fontes AP
Eur J Med Chem; 2009 Oct; 44(10):4107-11. PubMed ID: 19482387
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antimycobacterial evaluation of certain fluoroquinolone derivatives.
Zhao YL; Chen YL; Sheu JY; Chen IL; Wang TC; Tzeng CC
Bioorg Med Chem; 2005 Jun; 13(12):3921-6. PubMed ID: 15911308
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
[TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Pakistan 2010-2014: Implications for disease control.
Jabeen K; Shakoor S; Malik F; Hasan R
Int J Mycobacteriol; 2015 Mar; 4 Suppl 1():47-8. PubMed ID: 27128617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
